MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Topic
Psoriasis: Treatment and Pathogenesis
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

2,393 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
2,393 works in the cohort · of 4,299,418page 17 of 48

Labels cover 8 of 2,393 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 2,393 of 2,393 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

affno abstractunlabeled
Effectiveness and safety of guselkumab in 50 patients with moderate to severe plaque psoriasis who had previously been treated with other biologics: a retrospective real‐world evidence study
Jakob F. Schwensen, Valdemar Wendelboe Nielsen, C. Nissen, Carsten Sand, Robert Gniadecki, Simon Francis Thomsen
2020· letter· en· Journal of the European Academy of Dermatology and Venereology· Immunology and Microbiology
machine prediction:candidate · noneconsensus · none
20
citations
affno abstractunlabeled
Assessing adherence with phototherapy protocols
Sunil Kalia, Bez Toosi, Nick Bansback, Arezoo Astaneh, Youwen Zhou, Jerry Shapiro +1 more
2014· article· en· Journal of the American Academy of Dermatology· Immunology and Microbiology
machine prediction:candidate · noneconsensus · none
19
citations
afffundno abstractunlabeled
Addressing comorbidities in psoriatic disease
Priya Patel, Cheryl F. Rosen, Vinod Chandran, Yang Justine Ye, Dafna D. Gladman
2017· article· en· Rheumatology International· Immunology and Microbiology
machine prediction:candidate · noneconsensus · none
19
citations
venueno affunlabeled
Differential Diagnosis of Psoriasis
Nicola Balato, Luisa Di Costanzo, Anna Balato
2009· article· en· Journal of Rheumatology Supplement· Immunology and Microbiology
machine prediction:candidate · noneconsensus · none
19
citations
venueno affunlabeled
Concept of Remission in Chronic Plaque Psoriasis
Paolo Gisondi, Marco Di Mercurio, Luca Idolazzi, G. Girolomoni
2015· review· en· Journal of Rheumatology Supplement· Immunology and Microbiology
machine prediction:candidate · noneconsensus · none
19
citations
affunlabeled
Rituximab Induced Psoriasis in an Infant
Loretta Fiorillo, Charles Wang, Imam Hemmati
2014· article· en· Pediatric Dermatology· Immunology and Microbiology
machine prediction:candidate · noneconsensus · none
19
citations
affunlabeled
Oral Icotrokinra for Plaque Psoriasis in Adults and Adolescents
Robert Bissonnette, Jennifer Soung, Adelaide A. Hebert, Andrew Pink, Andreas Pinter, Angela Moore +10 more
2025· article· en· New England Journal of Medicine· Immunology and Microbiology
machine prediction:candidate · noneconsensus · none
19
citations
fundno affunlabeled
Malignancy Rates in Brodalumab Clinical Studies for Psoriasis
Alice B. Gottlieb, Mark Lebwohl, Clive Liu, Robert J. Israel, Abby Jacobson
2020· article· en· American Journal of Clinical Dermatology· Immunology and Microbiology
machine prediction:candidate · noneconsensus · none
18
citations
affno abstractunlabeled
Once-daily oral icotrokinra versus placebo and once-daily oral deucravacitinib in participants with moderate-to-severe plaque psoriasis (ICONIC-ADVANCE 1 & 2): two phase 3, randomised, placebo-controlled and active-comparator-controlled trials
Linda Stein Gold, April W. Armstrong, Robert Bissonnette, Nina Magnolo, Ronald Vender, Michael Sebastian +23 more
2025· article· en· The Lancet· Immunology and Microbiology
machine prediction:candidate · noneconsensus · none
18
citations

How this was built: Screen · Findings · About